Diethylstilbestrol | Stilbestrol | ERR | AmBeed-信号通路专用抑制剂

首页 / / / / Diethylstilbestrol/己烯雌酚

Diethylstilbestrol/己烯雌酚 {[allProObj[0].p_purity_real_show]}

货号：A174248 同义名： Stilbestrol

Diethylstilbestrol 是一种合成非类固醇雌激素，产生与天然雌二醇相似的药理学效应，常用于雌激素缺乏及激素失衡相关研究。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Diethylstilbestrol/己烯雌酚化学结构
CAS号：56-53-1

Diethylstilbestrol/己烯雌酚 3D分子结构
CAS号：56-53-1

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]}	现货	1周咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Diethylstilbestrol/己烯雌酚纯度/质量文件产品仅供科研

货号：A174248 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]; • Cell, 2025. Ambeed. [ A122167 ]; • Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]; • Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]; • Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]; 更多 >

Diethylstilbestrol/己烯雌酚生物活性

描述

Diethylstilbestrol is a synthetic estrogen receptor agonist structurally related to estradiol. Diethylstilbestrol at 20µM results in 30±13% and 43±4% displacement of [³H]-estradiol from the sex hormone-binding globulin steroid-binding site in the serum and dextran-coated charcoal-treated serum^[3]. Prostate cancer PC-3 cells treated with 30µM diethylstilbestrol for 72 hours show smaller nuclei compared with the control group. Diethylstilbestrol at 15 and 30µM induces apoptosis of androgen-insensitive prostate cancer cells^[4].

Diethylstilbestrol/己烯雌酚细胞实验

Cell Line Human umbilical vein endothelial cells (HUVECs) embryonic thymocytes embryonic thymocytes chicken oviductal epithelial cells (cOECs)	Concentration	Treated Time	Description	References
Human umbilical vein endothelial cells (HUVECs)	25-100 μM		DES significantly reduced HUVECs viability, inhibited VEGF-mediated wound closure and migration, and diminished capillary-like tube formation.	Clin Transl Med. 2020 Jun;10(2):e47.
embryonic thymocytes	25 μM	18-24 h	To investigate the effects of DES on embryonic thymocyte death and differentiation, results showed DES induced cell death.	Int J Mol Sci. 2021 Sep 20;22(18):10138.
embryonic thymocytes	50 μM	18-24 h	To investigate the effects of DES on embryonic thymocyte death and differentiation, results showed DES induced cell death.	Int J Mol Sci. 2021 Sep 20;22(18):10138.
chicken oviductal epithelial cells (cOECs)	100 μM	1 week	Upregulated oviduct-specific genes (OVA, OVM, LYZ, AVD, ESR1) and enhanced secretion of EGFP and OVA proteins	Poult Sci. 2024 Jun;103(6):103723.

Diethylstilbestrol/己烯雌酚动物实验

Species Zebrafish Mice	Animal Model Juvenile zebrafish Male mouse model	Administration	Dosage	Frequency	Description	References
Zebrafish	Juvenile zebrafish	Water exposure	100 and 1000 ng/L	From 10 to 90 dpf, exposed in three stages (initial development stage (IDS, 10-25 dpf), gonadal differentiation stage (GDS, 25-45 dpf), and gonadal maturity stage (GMS, 45-60 dpf))	To investigate the effects of DES on zebrafish gonad development and endocrine disruption mechanism at different developmental stages. Results showed that DES exposure during the gonadal differentiation stage (GDS) significantly reduced growth indicators (body length,, etc.) and significantly increased the proportion of females (59.65%), indicating a bias towards female differentiation.	Biomolecules. 2021 Jun 25;11(7):941
Mice	Male mouse model	Oral	0.2 µg/kg	Once daily from GD 11 to 17 and from PND 1 to 15	To investigate the effects of perinatal DES exposure on the adult male urogenital tract, results showed DES exposure led to enlarged prostates, enlarged bladders, and urethral obstruction.	Int J Mol Sci. 2020 May 30;21(11):3902

Diethylstilbestrol/己烯雌酚临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT00428948	Polycystic Kidney Disease, Aut... 展开 >>osomal Dominant 收起 <<	Phase 3	Completed	-	-
NCT00428948	-		Completed	-	-
NCT01212991	Prostate Cancer	Phase 3	Active, not recruiting	December 28, 2018	-

Diethylstilbestrol/己烯雌酚参考文献

[1]Tremblay GB, Kunath T, et al. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. Genes Dev. 2001 Apr 1;15(7):833-8.

[2]Sharpe RM, Atanassova N, et al. Abnormalities in functional development of the Sertoli cells in rats treated neonatally with diethylstilbestrol: a possible role for estrogens in Sertoli cell development. Biol Reprod. 1998 Nov;59(5):1084-94.

[3]Hodgert Jury H, Zacharewski TR, Hammond GL. Interactions between human plasma sex hormone-binding globulin and xenobiotic ligands. J Steroid Biochem Mol Biol. 2000;75(2-3):167-176.

[4]Robertson CN, Roberson KM, Padilla GM, et al. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst. 1996;88(13):908-917.

Diethylstilbestrol/己烯雌酚实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

3.73mL

0.75mL

0.37mL

18.63mL

3.73mL

1.86mL

37.26mL

7.45mL

3.73mL

Diethylstilbestrol/己烯雌酚技术信息

CAS号	56-53-1
分子式	C₁₈H₂₀O₂
分子量	268.35
SMILES Code	OC1=CC=C(C=C1)/C(CC)=C(CC)/C2=CC=C(O)C=C2
MDL No.	MFCD00002373

别名	Stilbestrol
运输	蓝冰
InChI Key	RGLYKWWBQGJZGM-ISLYRVAYSA-N
Pubchem ID	448537

存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, room temperature

溶解方案

细胞实验：

DMSO: 50 mg/mL(186.32 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验：请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议现用现配，当天使用；以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

方案一

方案二

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00428948	Polycystic Kidney Disease, Aut... 展开 >>osomal Dominant 收起 <<	Phase 3	Completed	-	-
NCT00428948	-		Completed	-	-
NCT01212991	Prostate Cancer	Phase 3	Active, not recruiting	December 28, 2018	-
NCT01830621	Colorectal Carcinoma	Phase 3	Completed	-	-
NCT00287768	Gastric Cancer	Phase 3	Completed	-	-
NCT01212991	-		Active, not recruiting	-	-
NCT02004873	Class I or II Indication for I... 展开 >>mplantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National Guidelines 收起 <<	Not Applicable	Completed	-	-
NCT01066208	-		Unknown	December 2018	-
NCT02004873	-		Completed	-	-
NCT01329380	-		Completed	-	-
NCT02043288	Pancreatic Neoplasms	Phase 3	Unknown	March 2018	-
NCT02066467	-		Completed	-	-
NCT02239120	Stroke Second... 展开 >>ary Prevention 收起 <<	Phase 3	Completed	-	-
NCT02178956	Gastric Cancer ... 展开 >> Gastroesophageal Junction Cancer 收起 <<	Phase 3	Active, not recruiting	June 2019	-
NCT01214343	Advanced Hepatocellular Carcin... 展开 >>oma Carcinoma Carcinoma, Hepatocellular Liver Neoplasms Neoplasms 收起 <<	Phase 3	Unknown	September 2013	Japan ... 展开 >> National Cancer Center Hospital East Recruiting Kashiwa, Chiba, Japan, 277-8577 Contact: Masafumi Ikeda, Dr. Principal Investigator: Masafumi Ikeda, Dr. Kurume University Medical Center Recruiting Kurume, Fukuoka, Japan, 839-0863 Contact: Masatoshi Tanaka, Professor Principal Investigator: Masatoshi Tanaka, Professor Ogaki Municipal Hospital Recruiting Ogaki, Gifu, Japan, 503-8502 Contact: Takashi Kumada, Dr Principal Investigator: Takashi Kumada, Dr. Sapporo Medical University Recruiting Sapporo, Hokkaido, Japan, 060-8556 Contact: Junji Kato, Dr. Principal Investigator: Junji Kato, Dr. Sapporo-Kosei General Hospital Recruiting Sapporo, Hokkaido, Japan, 060-8556 Contact: Takumi Ohmura, Dr. Principal Investigator: Takumi Ohmura, Dr. Japanese Red Cross Takamatsu Hospital Recruiting Takamatsu, Kagawa, Japan, 760-0017 Contact: Chikara Ogawa, Dr. Principal Investigator: Chikara Ogawa, Dr. Mie University Hospital Recruiting Tsu, Mie, Japan, 514-8507 Contact: Katsuya Shiraki, Dr. Principal Investigator: Katsuya Shiraki, Dr. National Hospital Organization Nagasaki Medical Center Recruiting Ohmura, Nagasaki, Japan, 856-8562 Contact: Hiromi Ishibashi, Dr. Principal Investigator: Hiromi Ishibashi, Dr. Kawasaki Medical School Hospital Recruiting Kurashiki, Okayama, Japan, 701-0192 Contact: Keisuke Hino, Dr. Principal Investigator: Keisuke Hino, Dr. Ikeda Municipal Hospital Recruiting Ikeda, Osaka, Japan, 563-8510 Contact: Yasuharu Imai, Dr. Principal Investigator: Yasuharu Imai, Dr. Kinki University Hospital Recruiting Osaka-Sayama, Osaka, Japan, 589-8511 Contact: Masatoshi Kudo, Professor +81-72-366-0221 ext 3149 m-kudo@med.kindai.ac.jp Contact: Kazuomi Ueshima, Dr. +81-72-366-0221 ext 3525 kaz-ues@med.kindai.ac.jp Principal Investigator: Masatoshi Kudo, Professor Sub-Investigator: Kazuomi Ueshima, Dr. Principal Investigator: Kazuto Nishio, Professor Osaka University Hospital Recruiting Suita, Osaka, Japan, 565-0871 Contact: Hiroaki Nagano, Professor Principal Investigator: Hiroaki Nagano, Professor Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan, 181-8611 Contact: Junji Furuse, Professor Principal Investigator: Junji Furuse, Professor Musashino Red Cross Hospital Recruiting Musashino, Tokyo, Japan, 180-8610 Contact: Namiki Izumi, Dr. Principal Investigator: Namiki Izumi, Dr. Juntendo University Nerima Hospital Recruiting Nerima, Tokyo, Japan, 177-0033 Contact: Shigehiro Kokubu, Dr. Principal Investigator: Shigehiro Kokubu, Dr. Yamaguchi University Hospital Recruiting Ube, Yamaguchi, Japan, 755-8505 Contact: Isao Sakaida, Prof Principal Investigator: Isao Sakaida, Professor Chiba University Hospital Recruiting Chiba, Japan, 260-8677 Contact: Fumihiko Kanai, Dr. Principal Investigator: Fumihiko Kanai, Dr. Gifu Municipal Hospital Recruiting Gifu, Japan, 500-8513 Contact: Eiichi Tomita, Dr. Principal Investigator: Eiichi Tomita, Dr. Hiroshima City Hospital Recruiting Hiroshima, Japan, 730-8518 Contact: Yoshiyuki Kobayashi, Dr. Principal Investigator: Yoshiyuki Kobayashi, Dr. Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Hiroshi Aikata, Dr. Principal Investigator: Hiroshi Aikata, Dr. Kumamoto University Hospital Recruiting Kumamoto, Japan, 860-8556 Contact: Yutaka Sasaki, Professor Principal Investigator: Yutaka Sasaki, Professor Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Etsuro Hatano, Professor Principal Investigator: Etsuro Hatano, Professor Center for Gastroenterological and Hepatological Diseases Recruiting Miyazaki, Japan, 880-0003 Contact: Hidemori Sakamoto, Dr. Principal Investigator: Hidemori Sakamoto, Dr. Saiseikai Niigata Dai-ni Hospital Recruiting Niigata, Japan, 950-1104 Contact: Toru Ishikawa, Dr. Principal Investigator: Toru Ishikawa, Dr. Niigata University Medical and Dental Hospital Recruiting Niigata, Japan, 951-8520 Contact: Kouhei Akazawa Principal Investigator: Kouhei Akazawa Okayama University Hospital Recruiting Okayama, Japan, 700-8558 Contact: Kazuhide Yamamoto, Professor Principal Investigator: Kazuhide Yamamoto, Professor Osaka Red Cross Hospital Recruiting Osaka, Japan, 543-8555 Contact: Ikuo Osaki, Dr. Principal Investigator: Ikuo Osaki, Dr. The University of Tokushima Faculty of Medicine Recruiting Tokushima, Japan, 770-8503 Contact: Tetsuji Takayama, Dr. Principal Investigator: Tetsuji Takayama, Dr. Kyoundo Hospital Recruiting Tokyo, Japan, 101-0062 Contact: Shuntaro Obi, Dr. Principal Investigator: Shuntaro Obi, Dr. National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Takushi Okusaka, Dr. Principal Investigator: Takushi Okusaka, Dr. 收起 <<
NCT02366143	Carcinoma, Non-Small-Cell Lung	Phase 3	Active, not recruiting	December 22, 2019	-
NCT02620046	Colitis, Ulcerative ... 展开 >> Crohn Disease 收起 <<	Phase 3	Recruiting	February 10, 2022	-
NCT02486718	Non-Small Cell Lung Cancer	Phase 3	Active, not recruiting	September 25, 2026	-
NCT02205359	Heart Failure With Left Bundle... 展开 >> Branch Block 收起 <<	Not Applicable	Recruiting	March 2023	-
NCT02746471	-		Active, not recruiting	March 2022	-
NCT02697058	Metastatic Pancreatic Cancer	Phase 2	Completed	-	Japan ... 展开 >> Hirosaki University School of Medicine & Hospital Hirosaki-shi, Aomori-Ken, Japan, 036-8563 Chiba Cancer Center Chiba-shi, Chiba-Ken, Japan, 260-8717 National Cancer Center Hospital East Kashiwa-shi, Chiba-Ken, Japan, 277-8577 NHO Shikoku Cancer Center Matsuyama-shi, Ehime-Ken, Japan, 791-0280 NHO Kyushu Cancer Center Fukuoka-shi, Fukuoka-Ken, Japan, 811-1395 Kyushu University Hospital Fukuoka-shi, Fukuoka-Ken, Japan, 812-8582 Hokkaido University Hospital Sapporo-shi, Hokkaido, Japan, 060-8648 Kanagawa Cancer Center Yokohama, Kanagawa -ku, Japan, 241-8515 Yokohama City University Medical Center Yokohama-shi, Kanagawa-Ken, Japan, 232-0024 Kyoto University Hospital Kyoto-shi, Kyoto-Fu, Japan, 606-8507 NHO Osaka National Hospital Osaka-shi, Osaka-Fu, Japan, 540-0006 Osaka International Cancer Institute Osaka-shi, Osaka-Fu, Japan, 541-8567 Saitama Cancer Center Kitaadachi-gun, Saitama-Ken, Japan, 362-0806 Cancer Institute Hospital of JFCR Koto-ku, Tokyo-To, Japan, 135-8550 Kyorin University Hospital Mitaka-shi, Tokyo-To, Japan, 181-8611 National Cancer Center Hospital Chuo Ku, Tokyo, Japan, 104-0045 收起 <<
NCT02877134	Crohn Disease	Phase 2	Recruiting	March 11, 2022	-
NCT02848781	Ventricular Tachycardia (VT)	Not Applicable	Recruiting	February 2023	China ... 展开 >> Fuwai Cardiovascular Hospital Recruiting Beijing, China Contact: Yao Yan, MD Huaxi Hospital Recruiting Chengdu, China Contact: Jiang Jian, MD Guangdong General Hospital Recruiting Guangzhou, China Contact: Shulin Wu, MD Sir Run Run Shaw Hospital Recruiting Hangzhou, China Contact: Chenyang Jiang, MD Nanjing First Affiliated Hospital Recruiting Nanjing, China Contact: Minglong Chen, MD PLA Shenyang General Hospital Not yet recruiting Shenyang, China Contact: Zulu Wang, MD, PhD Japan Dokkyo Medical University, Saitama Medical Center Recruiting Saitama, Japan Contact: Shiro Nakahara, MD, PhD Kyorin University Hospital Recruiting Tokyo, Japan Contact: Akiko Ueda, MD, PhD Contact: Kyoko Soejima, MD Tsukuba University Recruiting Tsukuba, Japan Contact: Akihiko Nogami, MD, PhD Korea, Republic of Korea University Recruiting Seoul, Korea, Republic of Contact: Young Hoon Kim, MD, PhD Taiwan Taipei Veterans General Hospital Recruiting Taipei, Taiwan Contact: Shih-Ann Chen, MD 收起 <<
NCT02450331	Carcinoma, Transitional Cell	Phase 3	Active, not recruiting	May 10, 2022	-
NCT02657356	Connective Tissue Disease-Asso... 展开 >>ciated Pulmonary Arterial Hypertension 收起 <<	Phase 3	Recruiting	June 2020	-
NCT02914522	Ulcerative Colitis	Phase 3	Recruiting	December 2019	-
NCT02891226	Crohn's Disease	Phase 2	Recruiting	November 28, 2020	-
NCT02914535	Ulcerative Colitis	Phase 3	Enrolling by invitation	October 2022	-
NCT02914600	Crohn's Disease	Phase 3	Enrolling by invitation	October 2022	-
NCT02656238	-		Active, not recruiting	January 2020	-
NCT02993731	Carcinoma, Pancreatic Ductal	Phase 3	Recruiting	-	-
NCT03176771	Tardive Dyskinesia	Phase 2 Phase 3	Recruiting	July 2019	-
NCT03072238	Metastatic Prostate Cancer	Phase 3	Recruiting	November 18, 2023	-
NCT03245268	-		Recruiting	March 2, 2022	United States, California ... 展开 >> University of California San Diego Recruiting La Jolla, California, United States, 92093 Contact: Nick H Kim, Prof h33kim@ucsd.edu Contact: Michael M Madani, Prof mmadani@ucsd.edu United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alison S Witkin, Dr United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Robert Frantz, Prof United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Gustavo Heresi, Dr Austria University Clinics Recruiting Vienna, Austria Contact: Irene M Lang, Prof irene.lang@meduniwien.ac.at Belgium Universitaire Ziekenhuizen Leuven Recruiting Leuven, Belgium Contact: Laurent Godinas, Dr Contact: Marion Delcroix, Prof marion.delcroix@uzleuven.be Czechia General University Hospital Recruiting Prague, Czechia Contact: Pavel Jansa, Dr France Centre Hospitalier Universitaire Grenoble-Alpes Recruiting Grenoble, France Contact: Hélène Bouvaist, Dr L'Hôpital Marie Lannelongue Recruiting Le Plessis-Robinson, France Contact: Philippe Brenot, Prof Germany Kerckhoff-Klinik GmbH Recruiting Bad Nauheim, Germany Contact: Eckhard Mayer, Prof E.Mayer@kerckhoff-klinik.de Japan National Hospital Organization Okayama Medical Center Recruiting Okayama, Japan Contact: Hiromi Matsubara, Prof matsubara.hiromi@gmail.com National Cerebral and Cardiovascular Center Recruiting Osaka, Japan Contact: Takeshi Ogo, Prof Keio University Hospital Recruiting Tokyo, Japan Contact: Takashi Kawakami, Prof Kyorin University Hospital Recruiting Tokyo, Japan Contact: Toru Satoh, Prof Netherlands VU Medical Center Recruiting Amsterdam, Netherlands Contact: Anton Vonk Noordegraaf, Prof Poland European Health Center Otwock LLC Recruiting Warsaw, Poland Contact: Marcin Kurzyna, Prof United Kingdom Papworth Hospital Recruiting Cambridge, United Kingdom Contact: Joanna Pepke-Zaba, Prof joanna.pepke-zaba@nhs.net Contact: David Jenkins, Dr david.jenkins1@nhs.net 收起 <<
NCT02914561	Crohn's Disease	Phase 3	Recruiting	December 2019	-
NCT03416374	Relapsed and/or Refractory Mul... 展开 >>tiple Myeloma 收起 <<	Phase 4	Recruiting	May 31, 2021	Japan ... 展开 >> Kameda Medical Center Recruiting Kamogawa, Chiba, Japan The Jikei University Kashiwa Hospital Recruiting Kashiwa, Chiba, Japan Ogaki Municipal Hospital Recruiting Ogaki, Gifu, Japan Gunma University Hospital Recruiting Maebashi, Gunma, Japan Shibukawa Medical Center Recruiting Shibukawa, Gunma, Japan Kobe city Medical Center General Hospital Recruiting Kobe, Hyogo, Japan Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan Iwate Medical University Recruiting Morioka, Iwate, Japan Yokohama Municipal Citizen's Hospital Recruiting Yokohama, Kanagawa, Japan Suwa Red Cross Hospital Recruiting Suwa, Nagano, Japan Dokkyo Medical University Recruiting Koshigaya, Saitama, Japan Juntendo University Hospital Recruiting Bunkyo-ku, Tokyo, Japan Nippon Medical School Hospital Recruiting Bunkyo-ku, Tokyo, Japan Nihon University Itabashi Hospital Recruiting Itabashi-ku, Tokyo, Japan The Cancer Institute Hospital of JFCR Recruiting Koto-ku, Tokyo, Japan The Jikei University Hospital Recruiting Minato-ku, Tokyo, Japan Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan Japanese Red Cross Medical Center Recruiting Shibuya-ku, Tokyo, Japan Tokyo Disaster Medical Center Recruiting Tachikawa, Tokyo, Japan Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital Recruiting Hiroshima, Japan Kyoto Kuramaguchi Medical Center Recruiting Kyoto, Japan Niigata Cancer Center Hospital Recruiting Niigata, Japan Osaka Red Cross Hospital Recruiting Osaka, Japan 收起 <<
NCT03068130	Pulmonary Hypertension	Phase 3	Recruiting	December 2021	-
NCT03466411	Crohn's Disease	Phase 3	Recruiting	October 23, 2024	-
NCT00331435	Age Related Macular Degenerati... 展开 >>on 收起 <<	Phase 4	Completed	-	Japan ... 展开 >> Nagoya City University Hospital Aichi, Japan Nagoya University Aichi, Japan Kyushu University Fukuoka, Japan, 812-0054 Fukushima Medical University School of Medicine Fukushima, Japan, 960-1295 Gunma University Gunma, Japan Kagawa University Kagawa, Japan, 761-0793 Kyoto University Kyoto, Japan, 606-8507 Osaka University Osaka, Japan, 565-0871 Kansai Medical University Takii Hospital Osaka, Japan, 570-8507 Kansai Medical University Hirakata Hospital Osaka, Japan, 573-1191 Sapporo City general hospital Sapporo, Japan, 060-8604 Shiga University of Medical Science Shiga, Japan Surugadai Nihon University Hospital Tokyo, Japan, 101-8309 Kyorin University Tokyo, Japan, 181-8611 Toho University Tokyo, Japan Tokyo University Ohashi Medical Center Tokyo, Japan Yamanashi University Yamanashi, Japan 收起 <<
NCT03519945	Ulcerative Colitis	Phase 3	Recruiting	August 23, 2023	-
NCT03178552	Non-Small Cell Lung Cancer	Phase 2 Phase 3	Recruiting	January 2, 2022	-
NCT03524092	Ulcerative Colitis	Phase 3	Recruiting	March 22, 2022	-
NCT03041623	-		Recruiting	March 2021	-
NCT03639675	Glaucoma, Neovascular	Phase 3	Recruiting	June 30, 2019	Japan ... 展开 >> University of Fukui Hospital Recruiting Yoshida, Fukui, Japan, 910-1193 Tsukazaki Hospital Not yet recruiting Himeji, Hyogo, Japan, 671-1227 Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 St. Marianna University School of Medicine Hospital Recruiting Kawasaki, Kanagawa, Japan, 216-8511 Osaka University Hospital Not yet recruiting Suita, Osaka, Japan, 565-0871 Takatsuki Red Cross Hospital Recruiting Takatsuki, Osaka, Japan, 569-1096 Shimane University Hospital Recruiting Izumo, Shimane, Japan, 693-8501 Kyorin University Hospital Not yet recruiting Mitaka, Tokyo, Japan, 181-8611 Yamaguchi University Hospital Not yet recruiting Ube, Yamaguchi, Japan, 755-8505 Kyoto Prefectural University of Medicine Not yet recruiting Kyoto, Japan, 602-8566 收起 <<
NCT03518086	Ulcerative Colitis	Phase 3	Recruiting	December 29, 2021	-
NCT03622580	Diabetic Macular Edema	Phase 3	Recruiting	June 2, 2022	-
NCT01176565	Intracerebral Hemorrhage	Phase 3	Terminated(Planned interim ana... 展开 >>lysis no significant outcome differences between groups) 收起 <<	-	-
NCT02895815	Visual Acuity ... 展开 >> Geographic Atrophy Macular Degeneration 收起 <<	Phase 2	Withdrawn(Company business dec... 展开 >>ision) 收起 <<	August 19, 2022	Japan ... 展开 >> Nihon University Hospital Chiyoda, Japan, 101-8309 Kansai Medical University Hospital Hirakata, Japan, 573-1191 Kagoshima University Hospital Kagoshima, Japan, 890-8520 Kyorin University Hospital Mitaka, Japan, 181-8611 Aichi Medical University Hospital Nagakute, Japan, 480-1195 Nagoya City University Hospital Nagoya, Japan, 467-8602 Tokyo Women's Medical University Hospital Tokyo, Japan, 162-8666 Yokohama City University Medical Center Yokohama, Japan, 232-0024 收起 <<
NCT01960790	-		Completed	-	-
NCT01176565	-		Terminated(Planned interim ana... 展开 >>lysis no significant outcome differences between groups) 收起 <<	-	-
NCT03586973	Advanced Hepatocellular Carcin... 展开 >>oma 收起 <<	Phase 2	Recruiting	March 31, 2021	Japan ... 展开 >> Aichi Cancer Center Hospital Recruiting Nagoya, Aichi, Japan National Cancer Center Hospital East Not yet recruiting Kashiwa, Chiba, Japan Iizuka Hospital Recruiting Iizuka, Fukuoka, Japan Kurume University Hospital Not yet recruiting Kurume, Fukuoka, Japan Sapporo-Kosei General Hospital Recruiting Sapporo, Hokkaido, Japan Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan Kanagawa Cancer Center Recruiting Yokohama, Kanagawa, Japan Yokohama City University Medical Center Not yet recruiting Yokohama, Kanagawa, Japan Kindai University Hospital Recruiting Osakasayama, Osaka, Japan National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan Japanese Red Cross Musashino Hospital Active, not recruiting Musashino, Tokyo, Japan Chiba University Hospital Recruiting Chiba, Japan Hiroshima University Hospital Active, not recruiting Hiroshima, Japan Okayama University Hospital Not yet recruiting Okayama, Japan Osaka City University Hospital Recruiting Osaka, Japan Osaka International Cancer Institute Not yet recruiting Osaka, Japan 收起 <<
NCT02889653	-		Recruiting	March 2022	Japan ... 展开 >> National Cerebral and Cardiovascular Center Recruiting Suita, Osaka, Japan, 5658565 Contact: Shoichiro Sato National Hospital Organization Kyushu Medical Center Recruiting Fukuoka, Japan Contact: Yasushi Okada St. Marianna University Recruiting Kawasaki, Japan Contact: Yasuhiro Hasegawa Kobe City Medical Center General Hospital Recruiting Kobe, Japan Contact: Nobuyuki Sakai National Hospital Organization Nagoya Medical Center Recruiting Nagoya, Japan Contact: Satoshi Okuda Saga University Recruiting Saga, Japan Contact: Yusuke Yakushiji Tokushima University Not yet recruiting Tokushima, Japan Contact: Shinji Nagahiro Juntendo University Recruiting Tokyo, Japan Contact: Hiroyuki Daida Kyorin University Recruiting Tokyo, Japan Contact: Teruyuki Hirano 收起 <<
NCT00525330	Type 2 Diabetes	Phase 2	Completed	-	United States, California ... 展开 >> San Diego, California, United States 收起 <<
NCT00699751	Hormone Refractory Prostate Ca... 展开 >>ncer Bone Metastases 收起 <<	Phase 3	Completed	-	-
NCT00995345	-		Completed	-	-
NCT02628262	-		Completed	-	Japan ... 展开 >> Makoto Inoue Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT00699751	-		Completed	-	-
NCT00995345	Type 2 Diabetes	Phase 2	Completed	-	-
NCT03337763	-		Recruiting	December 2020	Japan ... 展开 >> Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan, 181-8611 Contact: Kyoko Soejima, Prof. 0422-47-5511 skyoko@ks.kyorin-u.ac.jp 收起 <<
NCT01167322	Malignant Glioma	Phase 3	Completed	-	Japan ... 展开 >> International Medical Center, Saitama Medical University Hidaka, Saitama, Japan, 350-1298 National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 104-0045 Kyorin University Hospital Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT00512785	Overactive Bladder	Phase 3	Completed	-	Japan ... 展开 >> Kanto Region Kanto, Japan Kinki Region Kinki, Japan 收起 <<
NCT01389193	Migraine Headache	Phase 1	Completed	-	Australia ... 展开 >> School of Medical sciences, University of Adelaide Adelaide, Australia 收起 <<
NCT01578304	Overactive Bladder	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 <<
NCT03673150	-		Not yet recruiting	November 15, 2020	France ... 展开 >> University Nice Hospital Not yet recruiting Nice, France, 06000 Contact: Patrick FENICHEL 33492035519 fenichel.p@chu-nice.fr Principal Investigator: Patrick FENICHEL, PUPH 收起 <<
NCT00340600	-		Active, not recruiting	-	United States, Massachusetts ... 展开 >> Boston University School of Public Health Boston, Massachusetts, United States, 02118-2354 收起 <<
NCT00281034	-		Completed	-	Japan ... 展开 >> Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital Tachikawa-City, Tokyo, Japan, 190-8531 收起 <<
NCT02818842	-		Recruiting	December 2020	France ... 展开 >> University Hospital of Toulouse Recruiting Toulouse, France, 31000 Contact: Christine Damase-Michel christine.damase-michel@univ-tlse3.fr 收起 <<
NCT01693471	-		Completed	-	Japan ... 展开 >> Senzoku Respiratory Disease and Allergy Clinic Ota-ku, Tokyo, Japan, 145-0063 收起 <<
NCT01340703	Optic Disc Pit Maculopathy	Not Applicable	Completed	-	Japan ... 展开 >> Kyroin University Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT03575702	Overactive Bladder	Phase 3	Completed	-	Russian Federation ... 展开 >> Family polyclinic №4, LLC Korolev, Russian Federation A.I. Evdokimov Moscow State University of Medicine and Dentistry, Municipal Clinical Hospital named after Spasokukotskiy S.I Moscow, Russian Federation N.I. Pirogov Russian National Research University Moscow, Russian Federation National Medical Radiological Center Moscow, Russian Federation National N.I. Pirogov Medical and Surgical Center Moscow, Russian Federation Rostov State Medical University Rostov-on-Don, Russian Federation All-Russian A.M. Nikiforov Center for Emergency and Radiation Medicine Saint Petersburg, Russian Federation Baltic Medicine LLC Saint Petersburg, Russian Federation I.P. Pavlov First St. Petersburg State Medical University Saint Petersburg, Russian Federation OrKli Hospital, LLC Saint Petersburg, Russian Federation St. Petersburg State-Funded Healthcare Institution St. Luka Clinical Hospital Saint Petersburg, Russian Federation 收起 <<
NCT02464800	-		Completed	-	Japan ... 展开 >> Makoto Inoue Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT00541853	Kidney, Polycystic, Autosomal ... 展开 >>Dominant 收起 <<	Phase 4	Unknown	November 2012	Japan ... 展开 >> Kyorin University School of Medicine Not yet recruiting Mitaka, Tokyo, Japan, 181-8611 Contact: Eiji Higashihara, M.D. 81+422475511 ext 5813 ehigashi@kyorin-u.ac.jp Contact: Kikuo Nutahara, M.D. 81-422475511 ext 5815 kinuta@kyorin-u.ac.jp Department of Urology, National Hospital Organaization Chiba-East Hospital Not yet recruiting Chiba, Chiba, Japan, 260-8712 Contact: Koichi Kamura, MD 81+432615171 ext 7607 kamura@cehpnet.com Toranomon Hospital Kajigaya, Kidney center Not yet recruiting Kanagawa, Japan, 213-8587 Contact: Yoshifumi Ubara, MD 81+448775111 ext 6064 ubara@toranomon.gr.jp Toranomon Hospital, Kidney center Not yet recruiting Tokyo, Japan, 105-8470 Contact: Kenmei Tkaichi, MD 81+335881111 ext 7065 takaichi@toranomon.gr.jp Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine Not yet recruiting Tokyo, Japan, 105-8471 Contact: Tatsuo Hosoya, MD 81+334331111 ext 3220 t-hosoya@jikei.ac.jp Contact: Kazushige Hanaoka, MD 81+334331111 ext 3221 khanaoka@jikei.ac.jp Department of Urology, Teikyo University, School of Medicine Not yet recruiting Tokyo, Japan, 173-8605 Contact: Shigeo Horie, MD 81+339641211 shorie@med.teikyo-u.ac.jp Contact: Satoru Muto, MD 81+33964-1211 muto@med.teikyo-u.ac.jp 收起 <<
NCT00928824	Blood Pressure	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Univessity School of Medicine Tokyo, Mitaka shi, Japan, 181-0004 收起 <<
NCT02650739	-		Completed	-	-
NCT02896972	Macular Hole Retinal Detachmen... 展开 >>t 收起 <<	Not Applicable	Completed	-	-
NCT03376776	-		Completed	-	Japan ... 展开 >> Makoto Inoue Mitaka-shi, Tokyo, Japan, 181-8611 收起 <<
NCT03522311	-		Completed	-	-
NCT01462734	-		Completed	-	Japan ... 展开 >> Kyorin University School Of Medicine Tokyo, Mitakasi Sinkawa6-20-2, Japan, 181-8611 收起 <<
NCT01674023	-		Completed	-	Japan ... 展开 >> Kyorin University School Of Medicine Mitakasi Sinkawa6-20-2, Tokyo, Japan, 181-8611 收起 <<
NCT01306487	-		Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01959776	Macular Hole	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT02120066	Submacular Hemorrhage ... 展开 >> Ruptured Retinal Arterial Macro Aneurysms 收起 <<	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT02528045	-		Completed	-	Japan ... 展开 >> Makoto Inoue Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT02528058	-		Completed	-	Japan ... 展开 >> Makoto Inoue Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT02761070	Glioblastoma ... 展开 >>Recurrence Progression 收起 <<	Phase 3	Recruiting	July 2023	Japan ... 展开 >> Hirosaki University School of Medicine Recruiting Hirosaki, Aomori, Japan, 036-8563 Contact: Kenichiro Asano, M.D. +81-172-39-5111 asanoken@hirosaki-u.ac.jp Ehime University Graduate School of Medicine Recruiting Shizukawa, Ehime, Japan, 791-0295 Contact: Shohei Kouno, M.D. +81-89-960-5338 kouno1220@gmail.com Iwate Medical University Recruiting Morioka, Iwate, Japan, 020-8505 Contact: Takaaki Beppu, M.D. +81-19-651-5111 tbeppu@iwate-med.ac.jp Tohoku University Graduate School of Medicine Recruiting Sendai, Miyagi, Japan, 980-8574 Contact: Masayuki Kanamori, M.D. +81-22-717-7000 mkanamori@med.tohoku.ac.jp Kansai Medical University Recruiting Hirakata, Osaka, Japan, 573-1191 Contact: Akio Asai, M.D. +81-72-804-0101 aasaikun@hirakata.kmu.ac.jp Contact: Masahiro Nonaka, M.D. +81-72-804-0101 nonakamasa65@gmail.com Osaka University Graduate School of Medicine Recruiting Suita, Osaka, Japan, 565-0871 Contact: Naoki Kagawa, M.D. +81-6-6879-3652 nkagawa@nsurg.med.osaka-u.ac.jp Saitama Medical University International Medical Center Recruiting Hidaka, Saitama, Japan, 350-1298 Contact: Ryo Nishikawa, M.D., Ph.D. +81-42-984-4111 rnishika@saitama-med.ac.jp Contact: Kazuhiko Misima, M.D., Ph.D. +81-42-984-4111 kmishima@saitama-med.ac.jp Kusyu University Graduate School of Medical Sciences Recruiting Fukuoka, Japan, 812-8582 Contact: Koji Yoshimoto, M.D., Ph.D. +81-92-642-5524 kyoshimo@ns.med.kyushu-u.ac.jp Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Kazuhiko Sugiyama, M.D. +81-82-257-5227 sugiyama-hma@umin.ac.jp Kagoshima University Graduate School of Medical and Dental Sciences Recruiting Kagoshima, Japan, 890-8520 Contact: Hirofumi Hirano, M.D. +81-99-275-5111 hirahira@m2.kufm.kagoshima-u.ac.jp Kitasato University School of Medicine Recruiting Kanagawa, Japan, 252-0374 Contact: Toshihiro Kumabe, M.D., Ph.D. +81-3-3972-8111 kuma@kitasato-u.ac.jp Kyoto University Graduate School of Medicine Recruiting Kyoto, Japan, 606-8507 Contact: Yoshiki Arakawa, M.D. +81-75-366-7776 yarakawa@kuhp.kyoto-u.ac.jp Osaka International Cancer Institute Recruiting Osaka, Japan, 541-8567 Contact: Manabu Kinoshita, M.D. +81-6-6945-1181 mail@manabukinoshita.com Nakamura Memorial Hospital Recruiting Sapporo, Japan, 060-8570 Contact: Kenichi Sato, M.D. +81-11-231-8555 satoken@med.nmh.or.jp Hokkaido University Graduate School of Medicine Recruiting Sapporo, Japan, 060-8648 Contact: Hiroyuki Kobayashi, M.D. +81-11-716-1161 hiro-ko@med.hokudai.ac.jp Shizuoka Canser Center Hospital Recruiting Shizuoka, Japan, 411-8777 Contact: Yoko Nakasu, M.D. +81-55-989-5222 y.nakasu@scchr.jp Contact: Kouichi Mitsuya, M.D. +81-55-989-5222 k.mitsuya@scchr.jp National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Yoshitaka Narita, M.D., Ph.D. +81-3-542-2511 yonarita@ncc.go.jp The University of Tokyo Hospital Recruiting Tokyo, Japan, 113-8655 Contact: Shota Tanaka, M.D. +81-3-5800-8853 tanakas-tky@umin.ac.jp Keio University Hospital Recruiting Tokyo, Japan, 160-8582 Contact: Hikaru Sasaki, M.D. +81-3-3353-1211 hsasaki@a5.keio.jp Nihon University School of Medicine Itabashi Hospital Recruiting Tokyo, Japan, 173-0032 Contact: Atsuo Yoshino, M.D. +81-3-3972-8111 yoshino.atsuo@nihon-u.ac.jp Contact: Shun Yamamuro, M.D. +81-3-3972-8111 yamamuro.shun@nihon-u.ac.jp Kyorin University Faculty of Medicine, Department of Neurosurgery Recruiting Tokyo, Japan, 181-8611 Contact: Keiichi Kobayashi, M.D., Ph.D. +81-422-47-5511 kekobayashi@kki.biglobe.ne.jp Contact: Motoo Nagane, M.D., Ph.D. +81-422-47-5511 mnagane@ks.kyorin-u.ac.jp 收起 <<
NCT01348035	-		Completed	-	Japan ... 展开 >> Department of Urology, Kyorin University Hospital Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01307072	-		Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01316003	-		Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01549249	Epiretinal Membrane	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01658761	Maculopathy H... 展开 >>igh Myopia Surgery 收起 <<	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01654783	-		Completed	-	Japan ... 展开 >> Tokyo Medical and Dental University Bunkyo-ku, Tokyo, Japan, 113-8519 收起 <<
NCT01758718	Down's Syndrome	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01862627	-		Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT02729662	Autosomal Dominant Polycystic ... 展开 >>Kidney Disease 收起 <<	Not Applicable	Active, not recruiting	September 30, 2021	Japan ... 展开 >> Kyorin University Hospital Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01959802	Macular Psudohole	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT03244007	-		Completed	-	Japan ... 展开 >> Makoto Inoue Mitaka-shi, Tokyo, Japan, 181-8611 收起 <<
NCT02628158	-		Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01381965	Macular Holes	Not Applicable	Completed	-	Japan ... 展开 >> Makoto Inoue Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01266746	-		Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT03150745	Cervical Dysplasia	Not Applicable	Recruiting	July 2017	Egypt ... 展开 >> Women Health Hospital - Assiut university Recruiting Assiut, Egypt, 71111 Contact: Mohammed K ALi, MD +201005537951 m_khairy2001@yahoo.com 收起 <<
NCT02322385	-		Completed	-	Japan ... 展开 >> Department of Polycystic Kidney Research, Kyorin University School of Medicine Mitaka, Tokyo, Japan, 181-8611 Department of Urology, Kyorin University Hospital Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT02217566	Prostatic Neoplasms	Phase 2	Active, not recruiting	October 31, 2018	Brazil ... 展开 >> Porto Alegre, Brazil Rio De Janeiro, Brazil Santo Andre, Brazil Sao Paulo, Brazil São Paulo, Brazil 收起 <<
NCT00136526	Prostate Cancer	Phase 2	Completed	-	-
NCT01758757	Proliferative Diabetic Retinop... 展开 >>athy 收起 <<	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT01959724	Macular Detachment ... 展开 >> Macular Retinoschisis Intrachoroidal Cavitation 收起 <<	Not Applicable	Completed	-	Japan ... 展开 >> Kyorin Eye Center Mitaka, Tokyo, Japan, 181-8611 收起 <<
NCT00316927	Prostate Cancer	Phase 3	Completed	-	United Kingdom ... 展开 >> Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Burnley General Hospital Burnley, England, United Kingdom, BB10 2PQ Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 3NG Eastbourne District General Hospital Eastbourne, England, United Kingdom, BN21 2UD Whipps Cross Hospital London, England, United Kingdom, E11 1NR Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Chelsea Westminster Hospital London, England, United Kingdom, SW10 9NH Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Milton Keynes General Hospital Milton Keynes, England, United Kingdom, MK6 5LD Churchill Hospital Oxford, England, United Kingdom, OX3 7LJ Oldchurch Hospital Romford, England, United Kingdom, RM7 OBE Torbay Hospital Torquay Devon, England, United Kingdom, TQ2 7AA Weston General Hospital Weston-super-Mare, England, United Kingdom, BS23 4TQ Worthing Hospital Worthing, England, United Kingdom, BN11 2DH Cancer Care Centre at York Hospital York, England, United Kingdom, Y031 8HE 收起 <<

Diethylstilbestrol/己烯雌酚 {[allProObj[0].p_purity_real_show]}

Diethylstilbestrol/己烯雌酚纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Diethylstilbestrol/己烯雌酚质控信息

Diethylstilbestrol/己烯雌酚生物活性

Diethylstilbestrol/己烯雌酚细胞实验

Diethylstilbestrol/己烯雌酚动物实验

Diethylstilbestrol/己烯雌酚临床研究

Diethylstilbestrol/己烯雌酚参考文献

Diethylstilbestrol/己烯雌酚实验方案

Diethylstilbestrol/己烯雌酚技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Diethylstilbestrol/己烯雌酚 {[allProObj[0].p_purity_real_show]}

Diethylstilbestrol/己烯雌酚 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Diethylstilbestrol/己烯雌酚 质控信息

Diethylstilbestrol/己烯雌酚 生物活性

Diethylstilbestrol/己烯雌酚 细胞实验

Diethylstilbestrol/己烯雌酚 动物实验

Diethylstilbestrol/己烯雌酚 临床研究

Diethylstilbestrol/己烯雌酚 参考文献

Diethylstilbestrol/己烯雌酚 实验方案

Diethylstilbestrol/己烯雌酚 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Diethylstilbestrol/己烯雌酚纯度/质量文件产品仅供科研

Diethylstilbestrol/己烯雌酚质控信息

Diethylstilbestrol/己烯雌酚生物活性

Diethylstilbestrol/己烯雌酚细胞实验

Diethylstilbestrol/己烯雌酚动物实验

Diethylstilbestrol/己烯雌酚临床研究

Diethylstilbestrol/己烯雌酚参考文献

Diethylstilbestrol/己烯雌酚实验方案

Diethylstilbestrol/己烯雌酚技术信息